年龄对子宫内膜癌女性肿瘤结局的预后影响与因果性:随机PORTEC-1、PORTEC-2和PORTEC-3试验的多方法分析
本研究利用1801名参与随机PORTEC-1、PORTEC-2和PORTEC-3试验的子宫内膜癌女性数据,采用多方法分析(包括非参数检验、多变量竞争风险分析和深度学习因果推断模型AutoCI),发现高龄与更具侵袭性的肿瘤特征相关,且为独立且因果相关的预后因素,作者建议不应仅基于年龄将老年女性排除在诊断评估、分子检测和辅助治疗之外。
要点
- 高龄与深肌层浸润、浆液性组织学及p53异常肿瘤频率更高相关。
- 年龄是总体复发(HR 1.02/年)和子宫内膜癌特异性死亡(HR 1.03/年)的独立危险因素。
- 年龄被识别为显著的因果变量,老年女性不应仅因年龄被排除在诊断评估、分子检测和辅助治疗之外。
核心结论
- 高龄与子宫内膜癌女性更具侵袭性的肿瘤特征相关,且独立且因果地与更差的肿瘤结局相关。
- 作者认为,不应仅基于年龄将老年子宫内膜癌女性排除在诊断评估、分子检测和辅助治疗之外。
研究设计与样本
- 多方法分析,使用随机PORTEC-1、PORTEC-2和PORTEC-3试验中1801名女性的数据。
- 队列包括714例中危、427例高中危和660例高危子宫内膜癌患者。
- 采用非参数检验分析年龄与临床病理及分子特征关联,多变量竞争风险分析确定年龄独立预后价值,并使用深度学习因果推断模型AutoCI分析年龄作为因果预后变量。
主要发现
- 中位随访时间(反向Kaplan-Meier法):PORTEC-1为12.3年(95%CI 11.9-12.6),PORTEC-2为10.5年(10.2-10.7),PORTEC-3为6.1年(5.9-6.3)。
- 总体复发和子宫内膜癌特异性死亡均随年龄显著增加。
- 老年女性深肌层浸润、浆液性肿瘤组织学及p53异常肿瘤的频率更高。
- 年龄是总体复发的独立危险因素(HR 1.02/年,95%CI 1.01-1.04;p=0.0012)。
- 年龄是子宫内膜癌特异性死亡的独立危险因素(HR 1.03/年,95%CI 1.01-1.05;p=0.0012),并被识别为显著的因果变量。
临床怎么用
- 作者认为,老年子宫内膜癌女性不应仅基于年龄被排除在诊断评估、分子检测和辅助治疗之外。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Numerous studies have shown that older women with endometrial cancer have a higher risk of recurrence and cancer-related death. However, it remains unclear whether older age is a causal prognostic factor, or whether other risk factors become increasingly common with age. We aimed to address this question with a unique multimethod study design using state-of-the-art statistical and causal inference techniques on datasets of three large, randomised trials. METHODS: In this multimethod analysis, data from 1801 women participating in the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials were used for statistical analyses and causal inference. The cohort included 714 patients with intermediate-risk endometrial cancer, 427 patients with high-intermediate risk endometrial cancer, and 660 patients with high-risk endometrial cancer. Associations of age with clinicopathological and molecular features were analysed using non-parametric tests. Multivariable competing risk analyses were performed to determine the independent prognostic value of age. To analyse age as a causal prognostic variable, a deep learning causal inference model called AutoCI was used. FINDINGS: Median follow-up as estimated using the reversed Kaplan-Meier method was 12·3 years (95% CI 11·9-12·6) for PORTEC-1, 10·5 years (10·2-10·7) for PORTEC-2, and 6·1 years (5·9-6·3) for PORTEC-3. Both overall recurrence and endometrial cancer-specific death significantly increased with age. Moreover, older women had a higher frequency of deep myometrial invasion, serous tumour histology, and p53-abnormal tumours. Age was an independent risk factor for both overall recurrence (hazard ratio [HR] 1·02 per year, 95% CI 1·01-1·04; p=0·0012) and endometrial cancer-specific death (HR 1·03 per year, 1·01-1·05; p=0·0012) and was identified as a significant causal variable. INTERPRETATION: This study showed that advanced age was associated with more aggressive tumour features in women with endometrial cancer, and was independently and causally related to worse oncological outcomes. Therefore, our findings suggest that older women with endometrial cancer should not be excluded from diagnostic assessments, molecular testing, and adjuvant therapy based on their age alone. FUNDING: None.
引用
- Wakkerman FC, Wu J, Putter H, et al. Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials. Lancet Oncol. 2024. PMID: 38701815. doi:10.1016/S1470-2045(24)00142-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。